Verastem (VSTM) EPS (Weighted Average and Diluted) (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.62% |
| Dec 31, 2025 | 78.52% |
| Sep 30, 2025 | -117.74% |
| Jun 30, 2025 | 35.42% |
| Mar 31, 2025 | 38.06% |
| Dec 31, 2024 | -158.33% |
| Sep 30, 2024 | -93.55% |
| Jun 30, 2024 | 75.40% |
| Mar 31, 2024 | -22.33% |
| Dec 31, 2023 | -37.33% |
| Sep 30, 2023 | 45.26% |
| Jun 30, 2023 | -1,612.50% |
| Mar 31, 2023 | 98.13% |
| Dec 31, 2022 | -4,644.44% |
| Sep 30, 2022 | 25.00% |
| Jun 30, 2022 | -33.33% |
| Mar 31, 2022 | 98.04% |
| Dec 31, 2021 | -3,430.77% |
| Sep 30, 2021 | -30.00% |
| Jun 30, 2021 | -11.11% |
| Mar 31, 2021 | 25.00% |
| Dec 31, 2020 | -250.00% |
| Sep 30, 2020 | 157.14% |
| Jun 30, 2020 | 60.00% |
| Mar 31, 2020 | 31.37% |
| Dec 31, 2019 | -24.39% |
| Sep 30, 2019 | 28.07% |
| Jun 30, 2019 | -9.62% |
| Mar 31, 2019 | -40.54% |
| Dec 31, 2018 | -27.59% |
| Sep 30, 2018 | 3.33% |
| Jun 30, 2018 | 26.83% |
| Mar 31, 2018 | 13.61% |